SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : 2026 TeoTwawKi ... 2032 Darkest Interregnum -- Ignore unavailable to you. Want to Upgrade?


To: sense who wrote (174361)7/6/2021 8:31:41 PM
From: TobagoJack  Respond to of 218430
 
in the meantime, another alphabet

am wondering how soon 'they' are going to tell us that whatever vaccine is good at xx% against Lambda

zerohedge.com

Lambda Variant's "Unusual" Mutations May Make It Resistant To Vaccines, Researchers Fear(monger) Authored by Isabel van Brugen via The Epoch Times,

Scientists are concerned that a newly labeled COVID-19 variant, first detected in Peru, may be resistant to COVID-19 vaccines due to “unusual” mutations.

[url=][/url]

The Lambda variant, also known as C.37, is believed to have first emerged in Peru in August last year, but has only been recognized as a potential global threat in recent weeks, with the World Health Organization (WHO) declaring it a variant of interest on June 17 after it appeared in several countries simultaneously.

The WHO said the variant’s “neutralizing antibodies” could increase its transmissibility or potentially increase its resistance. It was “associated with substantive rates of community transmission in multiple countries,” it said.

In Peru, the Lambda strain now accounts for 82 percent of new infections. Meanwhile Chile, Argentina, Brazil, Colombia, Ecuador, and Mexico, have all confirmed widespread cases of the variant.

WHO virologist Jairo Mendez-Rico told DW that although the strain may exhibit higher infection rates, there is no indication that it is more aggressive.

Mendez-Rico told the outlet that more data is needed to compare the newly labeled strain to other existing strains such as gamma (P.1) and delta (B.1.617.2), which have already been categorized by the WHO as variants of concern.

Jeff Barrett, director of the COVID-19 Genomics Initiative at the Wellcome Sanger Institute in the UK, told the Financial Times that it is challenging to “make sense of the threat from Lambda, using computational and lab data” because it has “rather an unusual set of mutations, compared with other variants.”

According to the Centers for Disease Control and Prevention, no cases of the Lambda strain have been recorded in the United States so far.

Researchers from the University of Chile in Santiago said in a study published in a preprint last week that the variant has “a considerable potential to become a variant of concern.”

“Our data show for the first time that mutations present in the spike protein of the Lambda variant confer escape to neutralizing antibodies and increased infectivity,” wrote researchers in the paper that has yet to be peer-reviewed.


“Considering that this variant has rapidly spread in Peru, Ecuador, Chile, and Argentina, we believe that Lambda has a considerable potential to become a variant of concern,” they wrote.


The WHO said that further studies are needed to “validate the continued effectiveness of vaccines” with the Lambda strain.



To: sense who wrote (174361)7/7/2021 1:52:25 AM
From: TobagoJack  Read Replies (1) | Respond to of 218430
 
Aussies waffling, turning scaredy cats

bloomberg.com

Sydney Lockdown Extended by One Week as Delta Outbreak Spreads
Georgina McKay
7 July 2021, 09:21 GMT+8
A two-week lockdown of Sydney will be extended for at least another seven days as authorities race to stamp out an outbreak of the delta variant that’s grown to more than 350 cases since mid-June and has spread to an aged-care facility.

Current stay-at-home orders -- except for exercise, essential shopping and medical care -- will remain in place in Greater Sydney until midnight on July 16, New South Wales state Premier Gladys Berejiklian told reporters Wednesday. The lockdown was originally scheduled to end on Friday.



A person walks along the boardwalk in Sydney on July 7.

Photographer: Lisa Maree Williams/Getty Images

“This delta strain is a game changer,” Berejiklian said when announcing the extension. “What we want to do is give us our best chance of making sure this is the only lockdown we have until the vast majority of our citizens are vaccinated. We know the vaccine is the key to our freedom.”

Covid-Hero Australia Now Vaccine Laggard as Lockdowns Bite

Sydney recorded 27 new cases in the community from the day before, with 13 of those in isolation during their infectious period. The infections include one resident and one staff member of an aged-care facility; Berejiklian said her government is considering whether to take “further actions” to restrict movements in areas of Sydney where the city’s new cases are most concentrated.

The lingering lockdown of some 6 million Australians during school holidays is a blow to the domestic tourism industry and yet again shows the limitations of the government’s strategy of trying to eliminate community transmission of the virus. While economies such as the U.K. and U.S. are preparing to open up, Australia’s international borders remain largely closed to non-residents and comparatively small clusters of the coronavirus make even domestic travel difficult as states and territories pull up the drawbridge.

The Australian Formula 1 Grand Prix that was scheduled to take place in Melbourne in late November has been canceled “due to restrictions and logistical challenges” relating to the pandemic, organizers said in a statement Tuesday.

A sluggish vaccine rollout is being blamed for the ongoing disruption. The nation has administered 8.4 million doses, only enough to fully cover an estimated 16.5% of the population, according to Bloomberg’s Covid-19 Vaccine Tracker. That compares with the U.S. at 51.7% and the U.K. at 59.4%.

The program has been hampered by confused messaging over the health risks of the AstraZeneca Plc. shot and supply-chain hold-ups from contracted drug-makers. The government has announced a four-phase plan to move from its current “Covid-zero” strategy to fully re-opening borders and living with the virus, but has provided no timeline.

That’s putting Prime Minister Scott Morrison, who faces elections next year, under pressure. Morrison’s personal approval rating has slipped from 57% to 51%, a Guardian Essential poll published Tuesday showed. A Newspoll published last week showed his conservative coalition had slipped 2 percentage points to trail the main opposition Labor party, 49% to 51%.

Before it's here, it's on the Bloomberg Terminal.
LEARN MORE